QA: Myriad Genetics INC in us_medicinal_products/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000899923_2020_Myriad_Genetics_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.3149976492712741, 'aggregate_val': 839100000, 'exp_sum': 638100000, 'exp_to_value': {'GeneralAndAdministrativeExpense': 555500000, 'ResearchAndDevelopmentExpense': 85900000, 'remainder_Expenses': -3300000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000899923, Myriad Genetics INC

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 200,400,000
2 remainder_Liabilities 273,400,000
3 AssetsCurrent 348,600,000
4 AssetsNoncurrent 54,900,000
5 PropertyPlantAndEquipmentNet 57,300,000
6 Goodwill 1,101,900,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 555,500,000
9 ResearchAndDevelopmentExpense 85,900,000
10 remainder_Expenses 197,700,000
11 remainder_Revenues 851,100,000
12 remainder_NetIncome -7,600,000
13 remainder_ComprehensiveNetIncome -1,100,000
  yvar yval
0 Liabilities 473,800,000
1 Assets 1,562,700,000
2 Expenses 839,100,000
3 Revenues 851,100,000
4 StockholdersEquity 1,088,900,000
5 NetIncome 4,400,000
6 ComprehensiveNetIncome 3,850,000
7 BaseVar 1,867,700,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.47
9 EconomicCapitalRatio 1.99

Edgar->Model Mapping

Feature Distribution

Change over Time